AR and prostate carcinoma: Previous studies revealed that niclosamide suppressed AR negative prostate cancer cell growth [28]; here we showed that both ARVib-7 and ARVib-31 suppressed DU145 and PC3 cells in a dose-dependent manner (Supplementary Fig. 5E).